Cynthia M Poulos, MD | |
17 South St, Northboro, MA 01532 | |
(508) 393-4544 | |
(508) 393-4692 |
Full Name | Cynthia M Poulos |
---|---|
Gender | Female |
Speciality | Plastic Surgery |
Location | 17 South St, Northboro, Massachusetts |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1902864531 | NPI | - | NPPES |
3118975 | Medicaid | MA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208200000X | Plastic Surgery | 78672 (Massachusetts) | Primary |
Mailing Address | Practice Location Address |
---|---|
Cynthia M Poulos, MD 17 South St, Northboro, MA 01532 Ph: (508) 393-4544 | Cynthia M Poulos, MD 17 South St, Northboro, MA 01532 Ph: (508) 393-4544 |
News Archive
The new health law has renewed concerns about some moral and religious issues, such as the government's role in providing sex education and health care workers' ability to opt out of providing end-of-life care and abortions.
The human appendix, a narrow pouch that projects off the cecum in the digestive system, has a notorious reputation for its tendency to become inflamed (appendicitis), often resulting in surgical removal.
Seaweed has long been a staple food in many Asian countries and has recently caught on as a snack food in America as a healthful alternative to chips. The edible algae that fall in the category of seaweed are low-calorie and packed with nutrients
NIH-supported scientists at Seaside Therapeutics in Cambridge, Mass., are beginning a clinical trial of a potential medication designed to correct a central neurochemical defect underlying Fragile X syndrome, the most common inherited cause of intellectual disability. There has to date been no medication that could alter the disorder's neurologic abnormalities. The study will evaluate safety, tolerability, and optimal dosage in healthy volunteers.
Oncothyreon Inc. today announced that Merck Serono, a division of Merck KGaA of Darmstadt, Germany, and its U.S. affiliate, EMD Serono, Inc., have temporarily suspended the worldwide clinical development program for Stimuvax(R) (BLP25 liposomal vaccine). The suspension is the result of a suspected unexpected serious adverse reaction in a patient with multiple myeloma participating in an exploratory clinical trial.
› Verified 4 days ago